{"created":"2023-05-15T15:00:14.339706+00:00","id":81751,"links":{},"metadata":{"_buckets":{"deposit":"8a011e50-70e8-45f7-83aa-7fbfce99f67e"},"_deposit":{"created_by":1,"id":"81751","owners":[1],"pid":{"revision_id":0,"type":"depid","value":"81751"},"status":"published"},"_oai":{"id":"oai:repo.qst.go.jp:00081751","sets":["10:29"]},"author_link":["923627","923625","923616","923619","923617","923618","923621","923628","923624","923623","923626","923620","923622"],"item_10005_date_7":{"attribute_name":"発表年月日","attribute_value_mlt":[{"subitem_date_issued_datetime":"2020-11-13","subitem_date_issued_type":"Issued"}]},"item_10005_description_5":{"attribute_name":"抄録","attribute_value_mlt":[{"subitem_description":"プレターゲティング法は、半減期の短い211Atによるがん治療に有用と考えられる。プレターゲティング法に応用可能なテトラジンに、211At標識部位として汎用されるベンゾエート構造、及び211Atと生体内で安定な結合を維持するネオペンチル構造を標識部位として導入した2種のテトラジン誘導体(Bn-Tz、Np-Tz)を設計・合成し、その基礎的評価を実施した。","subitem_description_type":"Abstract"}]},"item_10005_description_6":{"attribute_name":"会議概要（会議名, 開催地, 会期, 主催者等）","attribute_value_mlt":[{"subitem_description":"第60回日本核医学会学術総会","subitem_description_type":"Other"}]},"item_access_right":{"attribute_name":"アクセス権","attribute_value_mlt":[{"subitem_access_right":"metadata only access","subitem_access_right_uri":"http://purl.org/coar/access_right/c_14cb"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"鈴木, 博元(千葉大学)"}],"nameIdentifiers":[{"nameIdentifier":"923616","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"貝塚, 祐太(千葉大学)"}],"nameIdentifiers":[{"nameIdentifier":"923617","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"龍田, 真帆(東京工業大学)"}],"nameIdentifiers":[{"nameIdentifier":"923618","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"佐々木, 一郎"}],"nameIdentifiers":[{"nameIdentifier":"923619","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"渡辺, 茂樹"}],"nameIdentifiers":[{"nameIdentifier":"923620","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"佐藤, 由衣(千葉大学)"}],"nameIdentifiers":[{"nameIdentifier":"923621","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"山下, 紗葵(千葉大学)"}],"nameIdentifiers":[{"nameIdentifier":"923622","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"田中, 浩士(東京工業大学)"}],"nameIdentifiers":[{"nameIdentifier":"923623","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"石岡, 典子"}],"nameIdentifiers":[{"nameIdentifier":"923624","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"上原, 知也(千葉大学)"}],"nameIdentifiers":[{"nameIdentifier":"923625","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Ichiro, Sasaki","creatorNameLang":"en"}],"nameIdentifiers":[{"nameIdentifier":"923626","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Shigeki, Watanabe","creatorNameLang":"en"}],"nameIdentifiers":[{"nameIdentifier":"923627","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Noriko, Ishioka","creatorNameLang":"en"}],"nameIdentifiers":[{"nameIdentifier":"923628","nameIdentifierScheme":"WEKO"}]}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"jpn"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"conference object","resourceuri":"http://purl.org/coar/resource_type/c_c94f"}]},"item_title":"211At標識テトラジン誘導体のプレターゲティング用薬剤としての基礎的評価","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"211At標識テトラジン誘導体のプレターゲティング用薬剤としての基礎的評価"}]},"item_type_id":"10005","owner":"1","path":["29"],"pubdate":{"attribute_name":"公開日","attribute_value":"2021-02-01"},"publish_date":"2021-02-01","publish_status":"0","recid":"81751","relation_version_is_last":true,"title":["211At標識テトラジン誘導体のプレターゲティング用薬剤としての基礎的評価"],"weko_creator_id":"1","weko_shared_id":-1},"updated":"2023-05-15T20:49:01.391918+00:00"}